Papers
2
Total Citations
77
H-Index
2
About
Xiao-Cheng Wu is a leading cancer outcomes researcher whose work focuses on prostate cancer treatment, health-related quality of life, and the comparative effectiveness of surgical interventions. Her major contributions include pioneering population-based studies that critically evaluate the real-world harms and benefits of robotic versus open radical prostatectomy, providing essential evidence for clinical decision-making. Her landmark 2015 study, cited over 60 times, used population cohort data to compare the comparative harms of these surgical approaches, challenging assumptions about robotic surgery’s superiority. Wu also advanced the interpretation of patient-reported outcomes through her work on the EPIC-26 questionnaire, clarifying how domain scores translate into functional outcomes—a crucial step for setting realistic patient expectations after treatment. Her research has directly informed urological practice and health policy by grounding surgical debates in rigorous, population-level evidence. With her work shaping how clinicians and patients understand treatment trade-offs, Wu remains a vital voice in prostate cancer survivorship and outcomes research.
Research Focus
Key Achievements
Top Papers
- 1
- 2